NEW YORK (Reuters Health) – For the management uncomplicated hypertension, using initial low-dose, fixed-dose combination therapy is better than guideline-based treatment, according to a report in the April…
NEW YORK (Reuters Health) – Consolidation therapy with low-dose thalidomide and prednisolone can improve survival in patients with multiple myeloma who have undergone autologous stem-cell transplantation (ASCT), according…
NEW YORK (Reuters Health) – In patients with upper-extremity spasticity due to stroke or traumatic brain injury (TBI), botulinum toxin injections are safer and more effective than oral…
NEW YORK (Reuters Health) – In patients with chronic hepatitis C genotype 4, adding nitazoxanide to peginterferon alfa-2a and ribavirin improves the virologic response rates, new research shows.…
NEW YORK (Reuters Health) – The use of aspirin as a cardioprotective agent significantly reduces recurrence among patients being treated for high-grade, non-muscle-invasive bladder cancer, the results of…
NEW YORK (Reuters Health) – Using a novel high-throughput screening assay, a team of scientists has discovered that two highly virulent viruses are susceptible in vitro to the…
NEW YORK (Reuters Health) – Nortriptyline is more effective than paroxetine CR in reducing symptoms of depression in patients with Parkinson’s disease, according to results of a small…
NEW YORK (Reuters Health) – Modafinil, a wake-promoting drug initially used to treat narcolepsy, increases extracellular dopamine — an effect that increases the drug’s potential for abuse —…
Paul H. Ratner, MD, MBA, Allergist, discusses the genesis of a new treatment for allergy to airborne pollens, developed by Ashok Wahi, BS, MS, PE. Marketed as Chloraseptic…
NEW YORK (Reuters Health) – As a treatment for chronic hepatitis B, telbivudine produces a better therapeutic response than does lamivudine in both HBeAg-positive and –negative patients, according…